Tema Neuroscience and Mental Health ETF Rating $25.40 -0.04 (-0.14%) As of 02/21/2025 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Neuroscience and Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MNTL Aggregate RatingModerate Buy 2.80Holdings in MNTL have an aggregate rating of Moderate Buy based on 586 analyst ratings issued in the past year covering 40 companies (92.1% of the portfolio).MNTL Aggregate Price Target$25.40High Prediction$25.40Average Prediction$25.40Low Prediction$25.40Holdings in MNTL have an aggregate price target of $25.40 and a range of $25.40 to $25.40 covering 40 companies (92.1% of the portfolio).MNTL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Neuroscience and Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 MNTL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.60%VRTXVertex Pharmaceuticals$484.24+0.8%4.1184 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News6.60%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement5.24%ARGXargenx$644.48-0.5%2.5004 of 5 stars2.86$658.39 2.2%22News CoveragePositive News4.74%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4472 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade4.34%TEVATeva Pharmaceutical Industries$16.75-1.5%2.8895 of 5 stars2.86$23.57 40.8%74.31%LLYEli Lilly and Company$874.12+0.1%4.8481 of 5 stars2.85$1,007.94 15.3%20Positive News3.28%NBIXNeurocrine Biosciences$120.69+3.9%4.9803 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up3.23%MDTMedtronic$89.95+2.3%4.2554 of 5 stars2.38$95.00 5.6%16Earnings ReportAnalyst ForecastAnalyst Revision3.13%BIIBBiogen$140.64+2.6%4.7395 of 5 stars2.43$211.85 50.6%30Analyst Forecast2.85%CRNXCrinetics Pharmaceuticals$37.48+1.7%4.1095 of 5 stars2.92$72.64 93.8%132.80%SYKStryker$382.59-1.0%4.7889 of 5 stars2.80$420.68 10.0%20Analyst ForecastInsider TradeAnalyst RevisionPositive News2.77%AXSMAxsome Therapeutics$137.75+6.7%4.5296 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.43%ITCIIntra-Cellular Therapies$128.60+0.0%3.8866 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage2.39%CPRXCatalyst Pharmaceuticals$21.63-1.9%4.8648 of 5 stars3.11$32.25 49.1%92.29%DNLIDenali Therapeutics$20.75-3.9%4.5154 of 5 stars2.93$37.42 80.3%152.28%IONSIonis Pharmaceuticals$32.33-1.1%4.4322 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.17%XENEXenon Pharmaceuticals$39.73+0.9%2.7109 of 5 stars3.11$57.38 44.4%9Options VolumeNews Coverage2.07%JAZZJazz Pharmaceuticals$136.01-0.5%4.9569 of 5 stars2.93$180.33 32.6%15Upcoming EarningsNews Coverage1.93%ALKSAlkermes$35.33-0.5%3.6917 of 5 stars2.82$38.36 8.6%111.92%SRPTSarepta Therapeutics$106.28-2.0%4.5034 of 5 stars2.87$176.77 66.3%23Upcoming Earnings1.89%ACADACADIA Pharmaceuticals$19.95-1.7%3.0693 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓1.74%DAWNDay One Biopharmaceuticals$12.43+1.6%2.1076 of 5 stars3.00$35.71 187.3%9Upcoming EarningsInsider TradeNews Coverage1.69%DXCMDexCom$88.78-0.6%4.7444 of 5 stars2.94$99.06 11.6%18Positive News1.64%SRRKScholar Rock$37.70-3.7%3.0395 of 5 stars3.14$40.43 7.2%7Insider TradeNews CoveragePositive News1.61%RNAAvidity Biosciences$31.12-4.3%1.4416 of 5 stars3.00$65.80 111.4%101.52%PENPenumbra$292.52-3.5%4.4645 of 5 stars2.88$292.64 0.0%16Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.45%BHVNBiohaven$36.90-7.2%3.3988 of 5 stars3.07$63.15 71.1%15Short Interest ↓Positive News1.43%OPCHOption Care Health$32.00-1.2%4.0285 of 5 stars2.75$32.25 0.8%8Positive News1.40%PTCTPTC Therapeutics$50.69+0.6%3.6081 of 5 stars2.47$58.85 16.1%15Analyst ForecastNews Coverage1.05%IMVTImmunovant$21.26+4.0%2.7438 of 5 stars3.00$45.90 115.9%120.98%ACHCAcadia Healthcare$39.65-2.5%4.8027 of 5 stars2.78$70.22 77.1%9News Coverage0.96%NTLAIntellia Therapeutics$12.17-0.7%4.3986 of 5 stars2.72$48.71 300.2%18News CoverageGap Up0.83%PRAXPraxis Precision Medicines$74.49-6.3%1.9403 of 5 stars2.90$145.20 94.9%100.80%PRTAProthena$15.56+2.0%3.125 of 5 stars2.71$45.83 194.6%7Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume0.69%TALKTalkspace$3.01-8.5%3.7073 of 5 stars3.00$4.38 45.3%6Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume0.60%DYNDyne Therapeutics$14.01+0.1%3.0875 of 5 stars3.08$49.91 256.2%130.59%VYGRVoyager Therapeutics$4.22-0.9%4.5332 of 5 stars3.11$15.72 272.4%9News Coverage0.33%ARVNArvinas$17.77-3.3%3.0809 of 5 stars3.00$60.00 237.6%12Gap Up0.31%SLDBSolid Biosciences$5.78-3.7%4.062 of 5 stars3.31$15.40 166.4%13Analyst ForecastAnalyst RevisionNews CoverageGap Up0.21%RAPPRapport Therapeutics$12.68-2.5%1.6248 of 5 stars3.00$35.00 176.0%3 This page (NASDAQ:MNTL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
